| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Homology Medicines, Inc. | CFO and President | Stock Option (Right to Buy) | 161K | $2.16M | $13.42 | Mar 25, 2024 | Direct |
| BICYCLE THERAPEUTICS plc | President and CFO | Ordinary Shares | 30.3K | $530K | $17.50 | Apr 3, 2023 | Direct |
| BICYCLE THERAPEUTICS plc | President and CFO | Employee Stock Option (right to buy) | 35K | Jan 3, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| QTTB | Homology Medicines, Inc. | Mar 25, 2024 | 1 | $0 | 4 | Mar 27, 2024 | CFO and President |
| QTTB | Homology Medicines, Inc. | Mar 25, 2024 | 0 | $0 | 3 | Mar 27, 2024 | CFO and President |
| BCYC | BICYCLE THERAPEUTICS plc | Apr 3, 2023 | 1 | -$7.94K | 4 | Apr 5, 2023 | President and CFO |
| BCYC | BICYCLE THERAPEUTICS plc | Jan 3, 2023 | 3 | -$52.7K | 4 | Jan 5, 2023 | President and CFO |
| BCYC | BICYCLE THERAPEUTICS plc | Jan 3, 2022 | 2 | $0 | 4 | Jan 5, 2022 | President and CFO |
| BCYC | BICYCLE THERAPEUTICS plc | Sep 2, 2021 | 3 | -$302K | 4 | Sep 3, 2021 | President and CFO |
| BCYC | BICYCLE THERAPEUTICS plc | Aug 26, 2021 | 6 | -$224K | 4 | Aug 27, 2021 | President and CFO |
| BCYC | BICYCLE THERAPEUTICS plc | Aug 23, 2021 | 3 | -$236K | 4 | Aug 25, 2021 | President and CFO |
| BCYC | BICYCLE THERAPEUTICS plc | Jul 29, 2021 | 5 | -$373K | 4 | Jul 30, 2021 | President and CFO |